Legend Biotech LEGN Earnings Call Transcripts

NASDAQ LEGN
$20.41 -3.88 (-15.97%)
At close: Nov 10, 2026 · 4:00 PM EST
6 earnings calls on file for Legend Biotech, from Q4 2024 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Legend Biotech Q2 2026 Earnings Call

Aug 11, 2026 6,261 words · 27 min read
  • Alan BashInterim Chief Executive Officer
  • Carlos SantosChief Financial Officer
  • Yuhong QiuInterim Head of R&D
  • Caroline LeCates PaulDirector of Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Legend Biotech Earnings Call Transcripts

Calls6
LatestAug 11, 2026
SinceQ4 2024

Fiscal 2026

Fiscal 2025

Fiscal 2024

All 6 Legend Biotech transcripts Register to get access to Legend Biotech’s earnings call transcripts.